Trial
NCT05463393
Xanthohumol as an Adjuvant Therapy in Critically Ill COVID-19 Patients
Early Phase ISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Medical University of Lublin
Collaborators
—
Condition
COVID-19 Respiratory Infection
Intervention
Xanthohumol - prenylated chalcone extracted from female inflorescences of hop cones (Humulus lupus). Hop-RXn™, BioActive-Tech Ltd, Lublin, Poland
Why stopped
We are waiting for the additional founds.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-01